Bioenergetics homeostasis is important for cells to sustain normal functions and defend against injury. The genetic controls of bioenergetics homeostasis, especially lipid metabolism, remain poorly understood in chronic obstructive pulmonary disease (COPD), the third leading cause of death in the world. Additionally, the biological function of most of the susceptibility genes identified from genome-wide association studies (GWASs) in COPD remains unclear. Here, we aimed to address (1) how fatty acid oxidation (FAO), specifically b-oxidation, a key lipid metabolism pathway that provides energy to cells, contributes to cigarette smoke (CS)-induced COPD; and (2) whether-and if so, how-FAM13A (family with sequence similarity 13 member A), a well-replicated COPD GWAS gene, modulates the FAO pathway. We demonstrated that CS induced expression of carnitine palmitoyltransferase 1A (CPT1A), a key mitochondrial enzyme for the FAO pathway, thereby enhancing FAO. Pharmacological inhibition of FAO by etomoxir blunted CSinduced reactive oxygen species accumulation and cell death in lung epithelial cells. FAM13A promoted FAO, possibly by interacting with and activating sirutin 1, and increasing expression of CPT1A. Furthermore, CS-induced cell death was reduced in lungs from Fam13a 2/2 mice. Our results suggest that FAM13A, the COPD GWAS gene, shapes the cellular metabolic response to CS exposure by promoting the FAO pathway, which may contribute to COPD development.
Clinical Relevance
Genome-wide association studies (GWAS) have been very successful in discovering genetic loci statistically associated with complex traits. However, understanding the biological function and molecular mechanisms of candidate genes within GWAS loci is an ongoing challenge. In this work, we connected a novel chronic obstructive pulmonary disease GWAS gene, FAM13A, with an important lipid metabolism pathway, fatty acid b-oxidation, at molecular levels in cellular and murine models. This novel genetic link between emphysema and lipid metabolism may open a new avenue for the treatment of chronic obstructive pulmonary disease, given the wide spectrum of pharmacological inhibitors of the fatty acid b-oxidation pathway.
Maintenance of cellular energy homeostasis is important under many physiological and pathological conditions that may well extend beyond metabolic diseases. This balance of cellular energy has not yet been well studied in lung diseases, including chronic obstructive pulmonary disease (COPD), the third leading cause of death in the United States (1) . COPD is a complex disease that is strongly influenced by both cigarette smoking and genetic predisposition. The known pathogenesis of COPD is highly complex and includes an imbalance between proteinase and antiproteinase (2) , oxidative stress (3), inflammation (4) , epithelial cell death (5, 6) , and mitochondrial dysfunction (7) . Recently, disrupted lipid metabolism was detected in patients with COPD (8) (9) (10) (11) as well as in a cigarette smoke (CS)-induced emphysema murine model (12) , suggesting a dysregulation of lipid metabolism during COPD development.
Fatty acids (FAs), as one of the main types of lipids, provide energy for many organisms through oxidation. The three types of FA oxidative degradation processes that occur in cells, namely, a-, b-, and v-oxidation, take place in specialized subcellular structures, the mitochondria and peroxisomes (13, 14) . Most FAs are catabolized by FA b-oxidation (FAO) inside mitochondria where even-numbered saturated FAs are oxidized, thus providing acetyl-coenzyme A (acetyl-CoA) as a substrate for the citric acid cycle. This process consists of two steps: first, longchain acetyl-CoA is transported from the cytosol into mitochondria by carnitine palmitoyltransferase (mainly CPT1); second, fatty acetyl-CoA is catalyzed by trifunctional enzymes inside the mitochondria. Through FAO, adenosine triphosphates (ATPs) are produced, accompanied by reactive oxygen species (ROS) (15) .
Under physiological conditions, glucose is generally the main energy source in lung epithelial cells. Acute CS exposure was shown to induce a switch from glucose to lipid as the main energy source and increase FAO in distal lung epithelial cells, likely by increasing CPT1A activity (16) , thereby generating ATP. However, whether-and if so, how-FAO contributes to CS-induced emphysema remains unexplored.
From genome-wide association studies (GWASs), several genetic loci have been unequivocally associated with COPD susceptibility in multiple cohorts. Among these loci, the FAM13A (family with sequence similarity 13 member A) locus at 4q24 (17, 18) repeatedly showed a strong association with COPD (19) , but the molecular mechanisms and the biological function of FAM13A in lungs are largely unknown (20) . Previously, we demonstrated increased expression of FAM13A in human COPD lungs compared with ex-smoker controls, and that
Fam13a
2/2 mice are resistant to CSinduced emphysema, which might be linked to increased levels of b-catenin and cell proliferation in the lungs of Fam13a 2/2 mice (21). Furthermore, the FAM13A locus has also been consistently linked with metabolic diseases (22, 23) , suggesting plausible roles of FAM13A in regulating energy homeostasis and metabolism.
In this work, we set out to understand the bioenergetics changes that occur in lung epithelial cells under CS exposure and to explore the roles of FAO in CS-induced lung injury, which is modified by the COPD GWAS gene FAM13A. By examining the results of CS exposure in murine and cellular models, we demonstrated that FAO mediates CS-induced ROS production and cell death, while FAM13A promotes FAO, possibly by increasing the expression of CPT1A, the key rate-limiting enzyme in FAO.
Materials and Methods
A full description of the experimental procedures used in this work is available in the online supplement.
Cell lines, Plasmids, Mice, and In Vivo CS Exposure All cells were purchased from ATCC (American Type Culture Collection, Manassas, VA). Human bronchial epithelial (16HBE) cells were cultured in Eagle's minimal essential medium. Human embryonic kidney (HEK) 293 cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum, penicillin (50 U/ml), and streptomycin (50 mg/ml). Mycoplasma was tested routinely using the Mycoalert Detection Kit (LT07-218; Lonza, Hopkinton, MA) in cells used in this study. 16HBE cells stably infected with control nontargeting short hairpin RNA (shRNA) or human FAM13A shRNA were established previously (21) . Full-length human FAM13A (NP_001252507.1) was cloned as described previously (21) . Fam13a 2/2 mice generated in a C57BL/6J background and littermate wildtype mice were exposed to CS as described previously (21) . At the end of the exposure period, the mice were killed by CO 2 narcosis and cervical dislocation, and the lungs were removed. Lung sections from mice exposed to CS or air for 1 month were assessed for cell death by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining. Primary lung alveolar epithelial cells isolated from mice that were exposed to air or CS for 5 months were assessed for mitochondrial respiration via Seahorse measurements (Seahorse Bioscience, North Billerica, MA). All mice were housed in the animal facility of Harvard Medical School under a 12-h light/12-h dark cycle.
Measurements of Mitochondrial Respiration
We used an Extracellular Flux Analyzer (Seahorse Bioscience) to measure the oxygen consumption rate (OCR), an indicator of mitochondrial respiration, in either 16HBE cells or primary murine distal lung epithelial cells in a 24-well plate. Briefly, cells were seeded directly into XF24 plates and mitochondrial respiration was measured in XF assay medium modified DMEM (Seahorse Bioscience) supplemented with D-glucose (25 mM) and pyruvate (1 mM). 16HBE cells were seeded at a density of 3 3 10 4 cells/well and OCR was measured using the MitoStress program. During the assay, oligomycin (2 mM), carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone (2 mM), and actinomycin/rotenone (1 mM of each) were sequentially added into each well to measure ATP production, maximum respiration, and proton leak (complex I driven), respectively. Primary distal lung epithelial cells were seeded into plates that were precoated with CellTak (Corning, Bedford, MA) at a density of 1 3 10 5 cells/well, followed by OCR measurements using the same program employed for the 16HBE cells. During the assay, oligomycin (4 mM), carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone (4 mM), and actinomycin/rotenone (2 mM of each) were added into each well sequentially.
Measurements of b-oxidation FAO was measured in 16HBE cells stably infected with FAM13A shRNA or overexpressing FLAG-tagged human FAM13A using previously described methods (21 
Statistical Method
We tested the data for normality before performing unpaired Student's t tests. Any data that were not normally distributed were analyzed using a nonparametric test. However, most of the in vitro data with a limited sample size showed a normal distribution. We then performed unpaired t tests with equal variance to compare the impacts of genotype and treatment under each given condition. Details regarding the statistical analysis are provided in the online supplement.
Results

CS Promotes FAO
To determine the impact of CS exposure on cellular mitochondrial respiration and cellular energy homeostasis, we exposed 16HBE cells, an immortalized HBE cell line, to 3% CS extracts (CSEs) for 12 h before measuring the OCR using the Seahorse method. Basal and maximum mitochondrial respiration increased by 50% and 100%, respectively, after CS treatment in 16HBE cells, accompanied by 60% increased ATP production after CS treatment ( Figures  1A-1E) . Furthermore, such CS-induced elevations in mitochondrial respiration were attenuated by etomoxir (Eto, 50 mM) (Figure 1 ), which inhibits CPT1A, the ratelimiting enzyme for FAO ( Figure E1A in the online supplement). In addition, genetically silencing CPT1A by small interfering RNA (siRNA) attenuated the induction of maximum mitochondrial respiration by CS in 16HBE cells ( Figure  E1B ). These results suggested that CS may enhance FAO and promote mitochondrial respiration in HBE cells. This was further confirmed by a 32% increase of FAO by direct measurements (24) in 16HBE cells exposed to CS ( Figure 1F ). Furthermore, expression of CPT1A (25) increased by 4-fold in 16HBE cells exposed to 3% CS for 12 h ( Figure 1G ), consistent with a previous report (16) . In sum, CS exposure promoted FAO and increased mitochondrial respiration in HBE cells.
FAO Mediates CS-Induced ROS Production and Cell Death
Given that mitochondrial respiration increased in bronchial epithelial cells after smoke exposure, we next assessed the impact of elevated FAO on CS-induced cell death and accumulation of ROS (5, 6, 26) , which contribute to emphysema development. Surprisingly, cells cotreated with Eto (50 mM) and CS showed improved cell viability (from 55% to 79%) compared with cells treated with CS alone (Figure 2A ). Similarly, genetic inhibition of FAO by CPT1A siRNA also significantly improved cell viability from 56% to 76% ( Figure 2B ), suggesting that a lower FAO rate is beneficial in preventing CS-induced cell death. Additionally, inhibition of FAO by Eto reduced CSE-induced mitochondrial and intracellular ROS production ( Figures  2C and 2D ). These results suggested that FAO mediates CS-induced cell death and mitochondrial-derived ROS accumulation. Consistently, the percentage of TUNELpositive cells (indicative of cell death) was reduced from 4% to 0.2% in human lung slices (27) cotreated with Eto (100 mM) and 6% CSE for 24 h compared with CSE treatment alone ( Figures 2E and 2F) .
To address the contribution of FAO to CS-induced cell death in vivo, we injected Eto intraperitoneally into C57BL/6 mice that were exposed to CS for 1 month, and then assessed cell death by TUNEL staining. The choice of 1 month of CS exposure was based on a previous report that CS-induced cell death was significantly increased after 1 month of CS exposure (28) . In our assays, the number of TUNELpositive cells increased 20-fold after 1 month of CS exposure. However, cell death was greatly attenuated in lungs from CSexposed mice cotreated with Eto (25 mg/kg, every other day) compared with mice exposed to CS alone ( Figures 2G and 2H ). Therefore, FAO mediates CS-induced cell death in vitro and in vivo.
FAM13A Promotes Mitochondrial Respiration by Enhancing FAO in HBE Cells
We then tested whether mitochondrial respiration is regulated by FAM13A. First, as indicated by the OCR, the maximum mitochondrial respiration was reduced by half and basal respiration showed a trend toward reduced OCR after FAM13A silencing in 16HBE cells ( Figures 3A, 3B Figure  E5A ). Similar results were also obtained in human 16HBE cells depleted of FAM13A ( Figure E5B ). These results suggested that FAM13A increases mitochondrial respiration by promoting FAO. Additionally, direct measurements on FAO demonstrated a 50% reduction after depletion of FAM13A and a 48% increase with overexpression of FAM13A in 16HBE cells ( Figure 3E) .
To determine the possible mechanism by which FAM13A regulates FAO, we measured the expression of different enzymes related to FAO in murine lungs from Fam13a 1/1 and Fam13a 2/2 mice that had been exposed to chronic CS for 6 months, at which point only the Fam13a 1/1 mice showed airspace enlargement (21 Figure E6A ). Reduced expression of CPT1A was also detected in 16HBE cells silenced for FAM13A ( Figure  E6B ). These results indicated that FAM13A may increase expression of CPT1A, the key rate-limiting enzyme in FAO. Furthermore, FAO increased 2-fold after overexpression of FAM13A but was reduced by 75% in 16HBE cells after CPT1A silencing regardless of overexpression of FAM13A, suggesting that FAM13A promotes FAO through CPT1A ( Figure 3F ). Consistently, overexpression of FAM13A increased mitochondria respiration, which was attenuated by CPT1A silencing in 16HBE cells ( Figure E7 ), indicating that FAM13A promotes oxygen consumption, likely through CPT1A.
It is noteworthy that the glycolysis rate, as measured by the Seahorse extracellular acidification rate, showed no difference in 16HBE cells overexpressing FAM13A. The extracellular acidification rates obtained in primary distal lung epithelial cells isolated from Fam13a 2/2 cells are also comparable to those determined in cells from Fam13a 1/1 mice ( Figure E8 ), suggesting minimal regulation of FAM13A during glycolysis in airway epithelial cells.
FAM13A Interacts with Sirtuin 1 and Promotes FAO through CPT1A
Previously, we demonstrated that FAM13A promotes the degradation of b-catenin, the key molecular mediator in the canonical Wnt pathway, by interacting with the protein phosphatase 2A (PP2A)/glycogen synthase kinase 3b (GSK-3b) complex (21) . It was also reported that the canonical Wnt pathway promotes FAO in hepatic cells (29) . Therefore, we assessed whether activation of the b-catenin/Wnt pathway regulates FAO in HBE cell lines. Surprisingly, FAO showed no changes in silencing of SIRT1. FAO significantly increased after treatment with the SIRT1 activator SRT1720 (3 mM) (34), but was reduced after silencing of SIRT1 by siRNA in 16HBE cells in the presence or absence of FAM13A ( Figure 4C ). Interestingly, overexpression of FAM13A failed to revert the impaired FAO due to SIRT1 silencing by SIRT1 siRNA (Figure 4D ), suggesting that SIRT1 is downstream of FAM13A in regulating FAO, and FAM13A promotes FAO through SIRT1. SIRT1 promotes FAO through transcriptional activation of multiple genes that are important for FAO, including CPT1A (35) . Given that expression of CPT1A is positively regulated by FAM13A ( Figure E6 ), we next assessed whether FAM13A promotes expression of CPT1A and FAO through SIRT1 in bronchial epithelial cells. First, the protein levels of CPT1A were reduced after SIRT siRNA transfection in 16HBE cells ( Figure 4E ). Second, overexpression of FAM13A increased the mRNA and protein levels of CPT1A, which was reverted by SIRT1 siRNA (Figures 4F and 4G ). This suggested that SIRT1 functions downstream of FAM13A to promote transcriptional activation of CPT1A.
Loss of Fam13a Attenuates CSEnhanced Mitochondria Respiration
We further assessed the impacts of CS exposure and Fam13a deficiency on the OCR in lung epithelial cells in vivo. We exposed age-matched Fam13a 1/1 and Fam13a 2/2 mice to CS for 1 month, and found that expression of Cpt1a increased in Fam13a 1/1 mice after 1 month of CS exposure ( Figure E10A ). In the meantime, we also set out to determine the impacts of FAM13A and chronic CS exposure on mitochondrial respiration in vivo. Primary distal lung epithelial cells were isolated and assessed for mitochondrial respiration. Maximum respiration increased by 50% in lung epithelial cells from Fam13a 1/1 mice after CS exposure ( Figures E10B-E10F ), consistent with a previous report (16) . In contrast, maximum mitochondrial respiration was significantly attenuated in lung epithelial cells from both air-and CS-exposed Fam13a 2/2 mice compared with cells from Fam13a 1/1 mice. We further confirmed that the CS-induced increase of OCR was impaired in lung epithelial cells derived from Fam13a 2/2 mice even after 5 months of chronic CS exposure ( Figures 5A and E11 ), suggesting that FAM13A mediates CS-induced mitochondrial respiration in distal lung epithelial cells.
Silencing of FAM13A Increases Resistance to CS-Induced Cell Death
Given that increased FAO mediates CSinduced cell death, we next assessed whether FAM13A also regulates CSinduced cell death and ROS production. First, silencing of FAM13A by two individual siRNAs conferred resistance to CSE-induced cell death ( Figure 6A ). In contrast, overexpression of human FAM13A sensitized cells to CSE-induced cell death and reverted the resistance to cell death conferred by FAM13A shRNA in 16HBE cells ( Figure 6B ). CSE treatment induced a 3-fold increase of intracellular ROS, which was completely attenuated upon FAM13A silencing ( Figure 6C ). We also detected a 4-fold increase in the number of dead cells positive for TUNEL signals in lungs from Fam13a 1/1 mice exposed to CS for 1 month, in contrast to a 1.64-fold increase in CS-exposed Fam13a 2/2 mice ( Figures 6D-6F ). These results suggested that FAM13A promotes CS-induced cell death in vivo and in vitro.
In summary, FAM13A promotes SIRT1 activity, increases CPT1A levels, and activates FAO. Upon CS exposure, CPT1A levels increase and FAO is activated, which mediates CS-induced ROS accumulation and cell death. Upon Fam13a deficiency, CPT1A levels are reduced, which attenuates CSinduced FAO and cell death ( Figure 6G ).
Discussion
GWASs have demonstrated a consistent association with COPD susceptibility at the FAM13A locus (17) . Despite increasing epidemiologic evidence linking lipid metabolism to CS-induced emphysema (36, 37) , whether-and if so, how-FAO, one of the major lipid metabolism pathways that are important for energy homeostasis, contributes to COPD pathogenesis has not yet been explored. Furthermore, how COPD GWAS genes determine CS-induced metabolic adaptation, as well as the biological consequences of such an adaptation, also remains enigmatic. Previously, we demonstrated that Fam13a 2/2 mice are resistant to CSinduced emphysema (21) . Herein, we demonstrate that FAM13A promotes FAO by upregulating CPT1A expression, and that chemical or genetic inhibition of FAO attenuates mitochondrial-derived ROS accumulation and cell death induced by CS exposure in vitro and in vivo. Hence, we connect FAM13A, one of the most consistent COPD genes, to CS-induced cell death through FAO, a druggable pathway that is important for energy balance and lipid metabolism.
Emphysema, which is characterized by the destruction of alveolar walls and reduced alveolar surface areas, represents one of the major pathological changes in human COPD lungs. CS-induced ROS accumulation and epithelial cell death contribute to CS-induced emphysema, but little is known about how this happens. The mitochondrion, as the main source of intracellular ROS, is not only passively stressed by CS in airway epithelial cells (26) but may also actively mediate CS-induced ROS production through elevated FAO, a metabolic adaptation that occurs in response to CS exposure. Thus, the mitochondrion has been suggested as a potential therapeutic target in COPD as well as in other lung diseases (38) .
Under physiological conditions, glucose is the major cellular energy source for generating ATP for various activities. However, upon CS exposure, airway epithelial cells utilize lipids to generate ATP by activation of FAO (16) (Figure 1 ). Direct induction of FAO by CS in airway epithelial cells may result from increased expression of CPT1A by CS. It is also possible that CS disrupts the extracellular matrix in COPD (39) , and loss of extracellular-matrix attachment may promote FAO in epithelial cells (40) . The change in glycolysis that occurs after CS exposure is more complicated: results from CS exposure in a murine model suggested reduced glycolysis in lung epithelial cells (16) , whereas patients with COPD demonstrated faster glucose metabolism with increased glycolysis (41) . Therefore, the molecular mechanism by which lung epithelial cells adapt metabolically in response to CS in vivo requires further investigation.
It is well accepted that chronic CS exposure in mice reduces body weight as well as fat mass (42) , which may result from reduced food intake due to loss of appetite (43) . Our study suggests another plausible reason for such reduced weight and fat mass after chronic CS exposure. In response to CS exposure, lung epithelial cells increased their mitochondrial respiration by enhancing FAO, which may exploit fat storage in adipose tissues to meet increased FA demands in lungs under stress conditions. Therefore, through such metabolic adaptation, lung epithelial cells are able to generate ATPs to meet their cellular energy needs. However, this metabolic adaptation works as a doubleedged sword, because sustained elevation in FAO may also aggravate CS-induced ROS accumulation, mitochondrial damage, and cell death (15) . This notion is supported by observations of improved cell viability and reduced mitochondrial ROS accumulation in vitro and ex vivo with Eto treatment during CS exposure (Figure 2 ). In addition, such continuous consumption of body fat may reduce body weight and fat mass in CS-exposed mice. Hence, environmental CS exposure leads to a rather systematic adaption in metabolism that may in turn determine CS-induced lung injury to various degrees.
Although FAM13A is one of the most replicated COPD GWAS genes, little is known about its biological functions. Previously, we showed that FAM13A interacts with PP2A and promotes the degradation of b-catenin in bronchial epithelial cells (21) . Therefore, increased levels of b-catenin detected in Fam13a 2/2 lungs may be associated with increased cell proliferation and lung repair capacity after CS-induced injury. Here, we argue that metabolic regulation may represent another complementary mechanism by which FAM13A promotes CS-induced emphysema. We found that FAM13A interacts with SIRT1, a well-known regulator of FAO. In previous studies, Sirt 1/2 mice showed spontaneous emphysema and SIRT1 levels were reduced in lung epithelial cells from COPD patients (44, 45) . Nuclear SIRT1 activates the transcription factor forkhead box O3 (FOXO3) and thus protects cells from oxidative-stress-induced injury (44, 45) . However, FAM13A mainly interacts with SIRT1 in the cytosol and promotes the deacetylation activity of cytosolic SIRT1, whose function is distinct from that of nuclear SIRT1. Cytoplasmic SIRT1 activates peroxisome proliferator-activated receptor gamma coactivator 1-a (PGC-1a) through deacetylation and increased expression of CPT1A (46, 47) . FAM13A interacts with SIRT1 and induces expression of CPT1A, thereby enhancing FAO, which mediates CSinduced cell death and ROS accumulation. The promotion of FAO by FAM13A through SIRT1 may function independently of its regulation on the b-catenin/Wnt pathway but complementarily determine the susceptibility to CS-induced emphysema.
It is noteworthy that FAM13A has also been consistently associated with lung function in the general population (48) , suggesting that the impact of FAM13A on lung function may not depend on smoking exposure. Consistent with this, a recent study suggested that both FAM13A and hedgehog interacting protein (HHIP) loci were significantly associated with lungfunction measurements in never-smokers (49) . This finding indicates that without CS exposure, an increase of FAM13A expression is sufficient to confer a risk of airway obstruction. In our experiments, we also found that overexpression of FAM13A increased the cellular FAO rate in bronchial epithelial cells independently of CS exposure ( Figure 3E) , and that increased FAO may predispose cells to an increased risk of cell apoptosis under CS treatment (Figure 1) . However, further investigation is required to determine whether the cellular FAO rate may modulate lung function under baseline in the absence of CS exposure. If so, FAM13A may determine normal lung function maintenance through modulating lipid metabolism in lung epithelial cells.
In summary, we have shown that CS-induced metabolic adaptation, mainly activation of FAO, may contribute to CS-induced lung epithelial cell death and increase ROS accumulation, and this process is modulated by the COPD susceptibility gene, FAM13A. n
